Clinical trial
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell…
NCT00025272 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00025272 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase II Study of Sequential Topotecan-Carboplatin-Etoposide in Patients With Extensive Stage Small Cell Lung Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, etoposide, topotecan hydrochloride, radiation therapy |
| Enrollment | 14 |
| Start date | Nov 1, 2001 |
| Primary completion | Jan 18, 2005 |
| Completion | Jan 18, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: